Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differences. Scafetta R, Zagami P, Del Re M, Criscitiello C, et al. Breast Cancer Res Treat 2025 Jan 8. doi: 10.1007/s10549-024-07595.

Read + Share

Amedeo Smart

Independent Medical Education

Scafetta R, Zagami P, Del Re M, Criscitiello C, et al. Oral selective estrogen receptor degraders for breast cancer treatment: focus on pharmacological differences. Breast Cancer Res Treat 2025 Jan 8. doi: 10.1007/s10549-024-07595.
PMID: 39776334